bims-midomiMDM2 and mitochondria
This report is maintained by Gavin McStay, Liverpool John Moores University. It brought out roughly 4 papers per issue.
As of 2025‒09‒13 at 23:58:02 the report has one subscriber.
0000‒00‒00
 Sign up
2025–09–14
2025–09–07
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2025–08–31
2025–08–24
2025–08–17
2025–08–10
2025–08–03
2025–07–27
2025–07–20
2025–07–13
2025–07–06
2025–06–29
2025–06–22
2025–06–15
2025–06–08
2025–06–01
2025–05–25
2025–05–18
2025–05–11
2025–05–04
2025–04–27
2025–04–20
2025–04–13
2025–04–06
2025–03–30
2025–03–23
2025–03–16
2025–03–09
2025–03–02
2025–02–23
2025–02–16
Gavin McStay also maintains bims-mikwok on “Mitochondrial quality control”since 2023–06–25, bims-resufa on “Respiratory supercomplex factors”since 2023–10–15 and bims-cytox1 on “Cytochrome oxidase subunit 1”.
Gavin McStay maintained a report bims-aporos on “Apoptosis and reactive oxygen species” from 2018–07–01 until 2019–08–18.
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-cepepe“Cell-penetrating peptides”, ∼ 13 p.p.i. ∼ 13 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meract“Metabolic reprogramming and anti-cancer therapy”, ∼ 16 p.p.i. ∼ 16 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-mibica“Mitochondrial bioenergetics in cancer”, ∼ 27 p.p.i. ∼ 27 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-tremyl“Therapy resistance biology in myeloid leukemia”, ∼ 32 p.p.i. ∼ 32 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-proteo“Proteostasis”, ∼ 35 p.p.i. ∼ 35 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-malgli“Biology of malignant gliomas”, ∼ 10 p.p.i. ∼ 10 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-hemali“Hematologic malignancies”, ∼ 19 p.p.i. ∼ 19 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2025‒09‒14 at 20:35.